$195 On-Demand Access Pass Available Now!

Speakers

Mike Arnold

Mike Arnold

CEO/Founder

Silo Wellness

Colin Beattie

Colin Beattie

Founder and CEO

Entheos

Debra Borchardt

Debra Borchardt

CEO, Co-Founder,

Green Market Report

David Feldman

David Feldman

Partner,

Hiller PC

Ben Greenzweig

Ben Greenzweig

CEO, Co-Founder

Momentum Events

George Goldsmith

George Goldsmith

Executive Chairman, Chief Executive Officer and Co-Founder

COMPASS Pathways

Shelby Hartman

Shelby Hartman

Chief Executive Officer, Co-Founder

DoubleBlind

Myles Katz

Myles Katz

Co-Founder

Synthesis

JR Rahn

JR Rahn

Founder, Director

MindMed

Shlomi Raz

Shlomi Raz

Founder & Chairman,

Eleusis

Ronan Levy

Ronan Levy

Founder

Field Trip Ventures

Matthew W. Johnson, Ph.D.

Matthew W. Johnson, Ph.D.

Professor of Psychiatry and Behavioral Sciences

Johns Hopkins University School of Medicine

Kelly Willenberg

Kelly Willenberg

President

Kelly Willenberg & Associates

Mike “Zappy” Zapolin

Mike “Zappy” Zapolin

Conscious Filmmaker,

“Lamar Odom: Reborn” 2020, “The Reality Of Truth” 2017

About the Summit

After spending decades in the shadows, psychedelics and empathogens have slowly reemerged as an effective treatment option for a wide variety of behavioral health issues including depression, anxiety, PTSD, chronic inflammation and addiction. With the cannabis legalization movement creeping towards maturity, American society has moved towards a more open-minded approach when it comes to this family of drugs that remain legally classified as a Schedule I substance under the Controlled Substances Act as the potential to provide relief to millions of afflicted people is an opportunity to large to ignore.

With a regulatory pathway already established, the next barrier is funding, but in order to drive greater investment, all interested parties must first understand the opportunity; from size and scope to models and applications.

Momentum’s Psychedelic Opportunity Summit has been designed to provide attendees with the scientific, medical, regulatory, economic, cultural and entrepreneurial knowledge need to determine an investment strategy. Whether you’re an investor, an insurance company, a pharmaceutical company, hospital system or entrepreneur, there is opportunity in the use of psychedelics to address a range of ailments including depression, anxiety, addiction, PTSD, chronic inflammation and alzheimers.

Attend this conference you will gain real world knowledge from industry veterans, experts, medical professionals and entrepreneurs including:

  • The Current State of Psychedelic Affairs, Research, Trials, and Conclusions
  • The Legal and Regulatory Environment for Psychedelics
  • Effectively Running Clinical Trials with a Psychedelic and Therapy Support
  • Economic Modeling
  • Current and Potential Future Innovations in Mental Health Care
  • Theoretical Incorporation of Psychedelic Treatment Into the US Payer Ecosystem

The Founder's Mission

The Psychedelic Opportunity Summit was founded by Momentum’s CEO Ben Greenzweig who’s passionate purpose is mental health. While developing conferences has been his speciality for more than two decades, as an open depressive who blogs and talks openly about his battles in hope of breaking down the stigma, Ben’s curiosity about his disease led him on a journey to discover the therapeutic potential of psychedelics and empathogens. It is from this passion that forged his determination to do his part to support the responsible growth of this industry and provide a way to help many, like him, who suffer.

“This could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?”

Shark Tank host Kevin O’Leary

Gain executive insights from:

  • COMPASS Pathways
  • U.S. Food and Drug Administration (FDA)
  • University of Alabama
  • Matthew W. Johnson, Ph.D. of Johns Hopkins
  • MAPS
  • MindMed
  • Entheos
  • Brooklyn Minds
  • Silo Wellness
  • Synthesis
  • Field Trip
  • El Ventures, Orthogonal Thinker
  • DoubleBlind
  • and many more!

Who Should Attend:

Titles:

  • Founder
  • Chief Executive Officer
  • Chief Commercial Officer
  • Chief Medical Officer
  • Chief Science Officer
  • Chief Research Officer
  • Chief Financial Officer
  • Chief Investment Officer
  • General Counsel
  • Executive Director
  • Managing Director
  • Partner
  • Principal
  • Entrepreneur

Head Of:

  • Research
  • CMC
  • Project Management
  • Regulatory Affairs
  • Billing
  • Clinical Trials
  • Strategy
  • Science
  • Development
  • Partnerships
  • Medical Affairs

Function:

  • Investment
  • Strategy
  • Research & Development
  • Finance
  • Innovation
  • Corporate Development
  • Medical Affairs

Industry:

  • Private Equity
  • Hedge Funds
  • Venture Capital
  • Insurance Companies
  • Hospital Systems
  • Pharma
  • Biotech
  • Clinical Trials
  • Legal

Partners & Supporters

Title Sponsor

Lead Sponsor

Organizing Partner

Supporting Sponsor

Supporting Sponsor

Associate Sponsor

Exclusive PR Partner

Media Partner

Media Partner

“High-profile Valley investor Peter Thiel made a bet (in 2017) on a company with an unusual idea for treating depression: psychedelics.”

Fortune Magazine

While Momentum Events support research on therapeutic applications of psychedelics, Momentum by no means promotes or condones the use of any illegal substance. Information conveyed during the conference is for educational purposes only, and is not intended to be used as treatment advice.

STATEMENT ON MEDICAL ADVICE: THE CONFERENCE, EVENT WEBSITE OR SPEAKERS MAY OFFER HEALTH, FITNESS, NUTRITIONAL, AND OTHER SUCH INFORMATION, BUT SUCH INFORMATION IS DESIGNED FOR EDUCATIONAL, AND INFORMATIONAL PURPOSES ONLY. THE INFORMATION CONTAINED ON THE SITE DOES NOT AND IS NOT INTENDED TO CONVEY MEDICAL ADVICE AND DOES NOT CONSTITUTE THE PRACTICE OF MEDICINE. YOU SHOULD NOT RELY ON THIS INFORMATION AS A SUBSTITUTE FOR, NOR DOES IT REPLACE PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT. WE ARE NOT RESPONSIBLE FOR ANY ACTIONS OR INACTION ON A USER’S PART BASED ON THE INFORMATION THAT IS PRESENTED ON THE SITE.

Start your learning and networking today! Join the Psychedelic Opportunity Summit LinkedIn group at: https://www.linkedin.com/groups/13807942

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Close Bitnami banner
Bitnami